Inventor
SHAH UNMESH
US10 patents
⚠️ This page may combine multiple inventors who share the name “SHAH UNMESH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
4 patentsUS9328138B2May 3, 2016
HCV NS3 protease inhibitors
MERCK SHARP & DOHME8 citations80
US8987195B2Mar 24, 2015
HCV NS3 protease inhibitors
MERCK SHARP & DOHME9 citations80
US11161819B2Nov 2, 2021
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
MERCK SHARP & DOHME0 citations50
US9708270B2Jul 18, 2017
Substituted spiropiperidinyl compounds useful as GPR120 agonists
MERCK SHARP & DOHME0 citations35
SCHERING CORP
2 patentsUS7572802B2Aug 11, 2009
7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine
SCHERING CORP7 citations71
US7465740B2Dec 16, 2008
2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
SCHERING CORP3 citations62
BOYLE CRAIG D
2 patentsUS8389532B2Mar 5, 2013
7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine
BOYLE CRAIG D2 citations59
US8466149B2Jun 18, 2013
6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I
BOYLE CRAIG D0 citations38